Acurx Pharmaceuticals, Inc. - 10-Q Filing

Acurx Pharmaceuticals reports Q3 financial results featuring significant warrant exercise activity and equity incentive plan updates.

SEC EDGAR ·

Tickers: $ACXP

Read the full article at SEC EDGAR

More Regulatory news